Through its subsidiary MLPW Invest AB, Atnotera AB has become a partner in the Center for Translational Research AB.

The acquisition is made by subscription of new share issue that gives MLPW Invest AB a total of 33% of the shares in the Center for Translational Research AB

CTC Clinical Trial Consultants AB continues to expand
CTC has recently implemented a directed rights issue to create conditions for continued expansion of the business and in connection with this formed the holding company Center for Translational Research AB which owns 100% of CTC AB

‍